Skip to navigationSkip to main contentSkip to right columnADVERTISEMENTExec-EdgeWed, September 9, 2026 at 5:46 PM GMT+2 1 min readBy Karen RomanVeraxa Biotech AG (Nasdaq: VRXA) said it appointed Raju Willener as Chief Financial Officer, having previously served as Director of Corporate Development at Exentis Group AG, before becoming its CFO in 2025.Mr. Willener has more than three decades of international financial leadership experience in global capital markets and all aspects of the biopharmaceutical development process, the company stated.READ MORE